Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

4.500%
0.01
4.500%
-
 
07:44 / Stuttgart Stock Exchange WKN: A2ADQM / Name: Recce Pharmaceuticals Ltd. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Recce Pharmaceuticals Ltd. Stock

Recce Pharmaceuticals Ltd. dominated the market today, gaining €0.010 (4.500%).

Pros and Cons of Recce Pharmaceuticals Ltd. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Patient Dosing and Multiple Sites Activated in Registrational Phase 3 Clinical Trial for Diabetic Foot Infections in Indonesia
Patient Dosing and Multiple Sites Activated in Registrational Phase 3 Clinical Trial for Diabetic Foot Infections in Indonesia

Highlights:

 

-          Patient dosing is underway for Registrational Phase 3 Clinical Trial for Diabetic Foot Infections (DFI), with five (5) clinical study sites now activated across one

RECCE® 327 Topical Gel Highly Effective and Accelerated Wound Healing for Burn Wounds in Rat Infection Models: https://www.irw-press.at/prcom/images/messages/2025/80678/Recce_120825_PRCOM.001.png
RECCE® 327 Topical Gel Highly Effective and Accelerated Wound Healing for Burn Wounds in Rat Infection Models

Highlights:

 

-          RECCE® 327 Topical Gel (R327G) highly effective against Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infected burn wounds (in-vivo)

 

-    

Placement of Entitlement Offer Shortfall
Placement of Entitlement Offer Shortfall

Highlights:

 

-          Entitlement Offer Shortfall of approximately 26.4 million shares placed to existing institutional and sophisticated investors raising A$7.4 million

 

-